Mitochondrial Dysfunction and Inflammation's Impact on Neuron Health in MS
A systematic review highlighted that mitochondrial dysfunction is a key factor in neuronal damage associated with multiple sclerosis (MS). It pointed to oxidative stress from inflammation compromising mitochondrial function, linking these mechanisms to disease progression.
- Tags
- #MSResearch
- Most relevant to
- —
- Human efficacy
- Not established from this source
- Mechanism
- Not reported
- Evidence strength
- Moderate
- Outcome
- Not reported
Why it matters
Understanding the role of mitochondrial dysfunction and oxidative stress in MS may guide future research into targeted therapies and interventions that address these specific pathways.
What this does not prove
The review does not provide original experimental data or results from clinical trials, limiting the applicability of its findings to clinical settings.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Systematic review
- Participants / samples
- Not reported
- Randomised
- Not applicable
- Controlled
- Not applicable
- Primary endpoint met
- Not applicable
- Relevant MS type
- All
- Publication date
- 2026-10-27
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Not classified
- Biological target
- Not reported
- Pathway
- Not reported
- Population
- Not reported
- Size of effect
- Not reported
- Secondary endpoints
- Not reported
- MRI endpoints
- Not reported
- Biomarkers
- Not reported
- Safety
- Not reported
Original sources
Supporting passages (13)
study designPublication types: Journal Article; Review
subjectsmultiple sclerosis (MS), and amyotrophic lateral sclerosis (ALS) place substantial burden on global public health.
findingsMounting evidence identifies mitochondrial dysfunction as a central contributor to neuronal damage and progressive brain functional decline.
findingsMutant huntingtin induces multiple mitochondrial lesions in HD, while inflammation‑triggered oxidative stress secondarily compromises mitochondrial function in MS.
limitationsBy synthesizing basic experimental findings and pre‑clinical and clinical trial progress, this review provides updated insights into the pathogenesis of neurodegenerative diseases and facilitates the development of precise mitochondrial‑targeted therapeutic regimens.
peer reviewedJournal of inflammation research
publication datePublication date: 2026-10-27
relevant ms typesmultiple sclerosis (MS), and amyotrophic lateral sclerosis (ALS)
peer reviewedPublication types: Journal Article; Review
study phasePublication types: Journal Article; Review
randomizedPublication types: Journal Article; Review
controlledPublication types: Journal Article; Review
primary endpoint metPublication types: Journal Article; Review
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.